FRE.DE · Fresenius SE & Co. KGaA

DAX · XETRA

Risiko 6/10 · Restructuring Mid-Stage · €44.30 ▲ 0.11%

Kennzahlen

• Price €44.30
• Market cap €25.0B
• P/E (ttm) 16.53
• Div yield 2.37%
• 52-wk range €35.11 – €52.96

Wichtigste Risiken

• Hospital division reimbursement reform (Germany/EU) (Helios revenue and margins) — HIGH
• Kabi volume and margin recovery execution (Kabi EBIT) — MED
• Vamed divestiture completion and residual exposure (Provisions & balance sheet clarity) — MED
• Leverage reduction pace amid capex needs (Credit metrics) — MED

Fazit

Restructuring is on track but not complete; hospital reimbursement reform and Kabi margin trajectory are the two metrics to watch.

Interaktive Analyse öffnen → Teilen

Recherche, keine Anlageberatung.